SM

Srinivas Madineni

Active Director Director DIN 07926420
DIN 07926420 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Srinivas Madineni

Data last updated:

Srinivas Madineni is a Director at 3C Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. 3C Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (FY 2019).

DIN 07926420
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2017
Oldest Company Age 10 yrs
Largest company 3C Pharmaceuticals Private Limited · ₹1.24 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
3C Pharmaceuticals Private Limited U52100TG2016PTC102897
Director01 Sep 20172016₹1.24 Cr (FY 2019)Active

Directorship timeline

Open interactive timeline →
3C Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinivas Madineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Madineni

Srinivas Madineni currently holds 1 directorship: 3C Pharmaceuticals Private Limited (Director, since 01 Sep 2017, revenue ₹1.24 Cr (FY 2019)).

Srinivas Madineni was first appointed on 01 Sep 2017 as Director at 3C Pharmaceuticals Private Limited.

The current boards of Srinivas Madineni's companies include Lella Shebha Pramodhini (3C Pharmaceuticals Private Limited), Srinivasa Reddy Patil (3C Pharmaceuticals Private Limited), Vijaya Bhaskar Reddy Devareddy (3C Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available